NOVAN, INC.

Profile

Company Names

NOVAN, INC.

Addresses

4222 EMPEROR BLVD, SUITE 200, DURHAM, NC 27703

4222 EMPEROR BLVD, SUITE 470, DURHAM, NC 27703

4222 EMPEROR BOULEVARD, SUITE 470, DURHAM, NC 27703

79 T.W. ALEXANDER DRIVE, BLDG 4401 RESEARCH COMMONS SUITE 105, RESEARCH TRIANGLE PARK, NC 27709

Phone Numbers

919-485-8080

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2006

State Incorporated:

DELAWARE

Total Amount Raised:

$105,342,405.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2015-12-01 
$32,840,304.00 
$32,840,304.00 
$0.00 
Equity 
5
2014-08-14 
$50,000,008.00 
$50,000,008.00 
$0.00 
Equity 
4
2014-02-24 
$3,502,125.00 
$3,502,125.00 
$0.00 
Debt 
3
2012-04-30 
$11,000,000.00 
$11,000,000.00 
$0.00 
Equity 
2
2010-11-03 
$5,999,968.00 
$5,999,989.00 
$21.00 
Equity 
1
2009-07-01 
$2,000,000.00 
$2,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
W 
KENT 
GEER 
DIRECTOR
NOVAN, INC.
W. 
KENT 
GEER 
DIRECTOR
NOVAN, INC.
F 
NEAL 
HUNTER 
DIRECTOR
NOVAN, INC.
F. 
NEAL 
HUNTER 
DIRECTOR
NOVAN, INC.   |  KNOW BIO, LLC
ROBERT 
A 
INGRAM 
DIRECTOR
NOVAN, INC.
G 
KELLY 
MARTIN 
DIRECTOR
NOVAN, INC.
G. 
KELLY 
MARTIN 
DIRECTOR
NOVAN, INC.   |  VIAMET PHARMACEUTICALS HOLDINGS LLC
SEAN 
 
MURPHY 
DIRECTOR
GAME CREEK FUND LP   |  NOVAN, INC.   |  GAME CREEK OFFSHORE FUND, LTD.   |  KNOW BIO, LLC   |  HARVEST PARTNERS STRUCTURED CAPITAL FUND II, L.P.   |  HARVEST PARTNERS STRUCTURED CAPITAL FUND II (PARALLEL), L.P.   |  XENEX DISINFECTION SERVICES INC.   |  POSEIDA THERAPEUTICS, INC.   |  HARVEST PARTNERS STRUCTURED CAPITAL FUND III (PARALLEL), L.P.   |  HARVEST STRATEGIC ASSOCIATES STRUCTURED CAPITAL FUND III, L.P.   |  HARVEST PARTNERS STRUCTURED CAPITAL FUND III, L.P.   |  TRISALUS LIFE SCIENCES, INC.   |  TRISALUS LIFE SCIENCES, INC.   |  TOGAL.AI, INC.   |  REMCO HOLDINGS LLC
JOHN 
W 
PALMOUR 
DIRECTOR
NOVAN, INC.
JOHN 
W. 
PALMOUR 
DIRECTOR
NOVAN, INC.
RICHARD 
 
PETERSON 
EXECUTIVE OFFICER
MARKETPSY LONG-SHORT FUND, L.P.   |  MYCELL TECHNOLOGIES LLC   |  NOVAN, INC.   |  CLARUS THERAPEUTICS HOLDINGS, INC.
ROBERT 
P 
RUSCHER 
DIRECTOR
NOVAN, INC.
MARK 
 
SCHOENFISCH 
EXECUTIVE OFFICER, DIRECTOR
NOVAN, INC.   |  CLINICAL SENSORS, INC.   |  KNOW BIO, LLC
NATHAN 
 
STASKO 
EXECUTIVE OFFICER, DIRECTOR
NOVAN, INC.   |  KNOW BIO, LLC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2015-12-30
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-12-01 
2015-12-16
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-12-01 
2015-03-30
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-08-14 
2014-08-29
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-08-14 
2014-03-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2014-02-24 
2013-02-28
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-04-30 
2012-05-31
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-04-30 
2011-09-29
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-11-03 
2011-08-29
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-11-03 
2011-01-18
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-11-03 
2010-11-18
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-11-03 
2009-07-02
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-07-01 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#